Beclomethasone Dipropionate Aerosol, Metered
Product Images NDC 13107-230

15 FDA label images from Aurolife Pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Beclomethasone Dipropionate (NDC 13107-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Beclomethasone Fig1)

Figure 1 (Beclomethasone Fig1)
Line graph showing mean change in AM PEF (L/min) over weeks 1-2, 3-4, and 5-6. It compares Beclomethasone Dipropionate HFA 40 mcg twice daily, 80 mcg twice daily, and HFA-134a placebo treatments, illustrating their effects on respiratory function over time.*
FDA Label Image

Package Label-principal Display Panel (40 mcg Inhalation Actuator Canister Label)

Package Label-principal Display Panel (40 mcg Inhalation Actuator Canister Label)
Label for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg by Aurobindo Pharma USA, Inc. The label states this is for oral inhalation with 120 metered inhalations and 8.7 g net contents. It includes storage instructions (20° to 25°C), warnings about pressure contents, and directions to refer to the package insert for use. The label features the NDC 13107-230-54 and distributor address.*
FDA Label Image

Package Label-principal Display Panel (40 mcg Inhalation Actuator Carton Label)

Package Label-principal Display Panel (40 mcg Inhalation Actuator Carton Label)
Packaging label for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg. The label indicates it is a metered aerosol for oral inhalation with 120 metered inhalations and 8.7 g net contents. It includes warnings, storage instructions, and mentions a dose counter. Distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (80 mcg Inhalation Actuator Label)

Package Label-principal Display Panel (80 mcg Inhalation Actuator Label)
Label for Beclomethasone Dipropionate HFA Inhalation Aerosol, 80 mcg strength. The label specifies use only with the 80 mcg Beclomethasone Dipropionate HFA canister. The label shows the Aurobindo logo and the code LM-3254 on a red background.*
FDA Label Image

Package Label-principal Display Panel (80 mcg Inhalation Actuator Canister Label)

Package Label-principal Display Panel (80 mcg Inhalation Actuator Canister Label)
Label for Beclomethasone Dipropionate HFA Inhalation Aerosol 80 mcg, a metered respiratory inhalation aerosol. The label includes directions to use the 80 mcg actuator only, with 120 metered inhalations and net contents of 8.7 g. Distributed by Aurobindo Pharma USA, Inc., it cautions to store at 20° to 25°C and keep out of reach of children.*
FDA Label Image

Package Label-principal Display Panel (80 mcg Inhalation Actuator Carton Label)

Package Label-principal Display Panel (80 mcg Inhalation Actuator Carton Label)
Label for Beclomethasone Dipropionate HFA Inhalation Aerosol 80 mcg, an oral inhalation aerosol with 120 metered inhalations per container by Aurolife Pharma LLC. Features include a dose counter and storage instructions with warnings. The label includes NDC 13107-231-54 and states the product is Rx only.*
FDA Label Image

Figure 2 (Beclomethasone Fig2)

Figure 2 (Beclomethasone Fig2)
A line graph comparing mean AM PEF (L/min) over weeks following oral steroid treatment under three treatments: Beclomethasone Dipropionate HFA 160 mcg twice daily, CFC-BDP 336 mcg twice daily, and HFA-134a placebo. The graph shows data points from run-in through week 10-12 with different performance levels for each treatment.*
FDA Label Image

Figure 3 (Beclomethasone Fig3)

Figure 3 (Beclomethasone Fig3)
A line graph depicting mean changes in FEV1 as a percentage of predicted values over six weeks. The graph compares multiple treatment groups, including different dosages and frequencies of Beclomethasone Dipropionate HFA and CFC-BDP. The x-axis represents weeks 1 through 6, while the y-axis shows mean change in FEV1 percentage from 0 to 30.*
FDA Label Image

Beclomethasone-fig4.jpg (Beclomethasone Fig4)

Beclomethasone-fig4.jpg (Beclomethasone Fig4)
An instructional diagram of a Beclomethasone Dipropionate metered aerosol inhaler, showing labeled parts including the metal canister, plastic actuator, mouthpiece, and cap. The diagram highlights the device components for respiratory inhalation use.*
FDA Label Image

Beclomethasone-fig5.jpg (Beclomethasone Fig5)

Beclomethasone-fig5.jpg (Beclomethasone Fig5)
An instructional diagram showing a dose counter on an inhaler device for Beclomethasone Dipropionate aerosol, metered respiratory inhalation. The diagram highlights the location of the dose counter displaying the number 120, indicating remaining doses.*
FDA Label Image

Beclomethasone-fig6.jpg (Beclomethasone Fig6)

Beclomethasone-fig6.jpg (Beclomethasone Fig6)
An instructional diagram showing a hand holding a Beclomethasone Dipropionate HFA inhalation aerosol canister, with labels indicating the mouthpiece and a removable cap being taken off. The image demonstrates removing the cap from the mouthpiece before use.*
FDA Label Image

Beclomethasone-fig7.jpg (Beclomethasone Fig7)

Beclomethasone-fig7.jpg (Beclomethasone Fig7)
An instructional diagram showing a Beclomethasone Dipropionate aerosol inhaler with a dose counter displaying the number 122. The image highlights the dose counter mechanism on the inhaler device, indicating remaining doses.*
FDA Label Image

Beclomethasone-fig8.jpg (Beclomethasone Fig8)

Beclomethasone-fig8.jpg (Beclomethasone Fig8)
An instructional illustration showing a person using a metered-dose inhaler. The person is placing the inhaler mouthpiece into their mouth and pressing down on the canister to release the aerosol dose, indicated by arrows showing downward pressure and forward inhalation.*
FDA Label Image

Package Label-principal Display Panel (40 mcg Inhalation Actuator Label)

Package Label-principal Display Panel (40 mcg Inhalation Actuator Label)
Label for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg, indicating use only with a 40 mcg Beclomethasone Dipropionate HFA canister. The label includes the Aurobindo logo and a registration code LM-3253 on a brown background.*
FDA Label Image

Chemical Structure (Beclomethasone Str)

Chemical Structure (Beclomethasone Str)
Chemical structure of Beclomethasone Dipropionate, showing its molecular framework including functional groups and stereochemistry as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.